Lineage, William Demant Partner to Develop ReSonance for Hearing
August 26, 2025
Three-year term intended to advance preclinical development of ReSonance Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf,” cell